John B Amos Cancer Center is categorized under Oncologists in Columbus, GA and active since 1995.
John B Amos Cancer Center was established in 1995, and today employs 1 to 4, earning $10.000.000 to $19.9999.999 per year. This is a Oncologists business, which does work in the B2C market, and is classified as a Oncologists, under code number 6223100 by the NAICS.
If you are seeking more information, feel free to contact Margaret Abrego, Manager at the company’s single location by writing to 1831 5th Avenue, Columbus, Georgia GA 31904 or by phoning (706) 320-8700. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | John B Amos Cancer Center |
| Contact Person: | Margaret Abrego, Manager |
| Address: | 1831 5th Avenue, Columbus, Georgia 31904 |
| Phone Number: | (706) 320-8700 |
| Website Address: | columbusregional.com |
| Annual Revenue (USD): | $10.000.000 to $19.9999.999 |
| Founded: | 1995 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Oncologists |
| SIC Code: | 8011 |
| NAICS Code: | 6223100 |
| Share This Business: |
John B Amos Cancer Center was started in 1995 to provide professional Oncologists under the SIC code 8011 and NAICS code 6223100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $10.000.000 to $19.9999.999 per annum.
Feel free to contact Margaret Abrego, Manager for inquiries that concern John B Amos Cancer Center by calling the company number (706) 320-8700, as your correspondence is most welcome. Additionally, the physical location of the single location of John B Amos Cancer Center can be found at the coordinates 32.48056,-84.98607 as well as the street address 1831 5th Avenue in Columbus, Georgia 31904.
For its online presence, you may visit John B Amos Cancer Center’s website at columbusregional.com and engage with its social media outlets through on Twitter and on Facebook.